ARTG 384118Bioinductive Implant with Arthroscopic Delivery System - Multi-purpose surgical mesh, collagen
ARTG ID: 384118 · Smith & Nephew Pty Ltd · Smith & Nephew Inc Endoscopy Division · Class III · Started February 16, 2022
Good Name: Smith & Nephew Pty Ltd - Bioinductive Implant with Arthroscopic Delivery System - Multi-purpose surgical mesh, collagen
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 384118
- Start Date
- February 16, 2022
- Effective Date
- May 02, 2024
- Country
- United States of America
- Address
- 150 Minuteman Road, ANDOVER, MA, 01810-1031
The REGENETEN Bioinductive Implant is a medical device intended for the management and protection of tendon injuries. The REGENETEN Bioinductive Implant is indicated for the management and protection of rotator cuff tendon injuries in which there has been no substantial loss of tendon tissue.
Access comprehensive regulatory information for Bioinductive Implant with Arthroscopic Delivery System - Multi-purpose surgical mesh, collagen in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 384118 and sponsored by Smith & Nephew Pty Ltd, manufactured by Smith & Nephew Inc Endoscopy Division in United States of America. The device registration started on February 16, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.